Safety and Efficacy of T89 in the Prevention and Treatment of Adults With Acute Mountain Sickness (AMS)
Clinical trial NCT04993729 · COMPLETED
Trial details
- NCT number
- NCT04993729
- Sponsor
- Tasly Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-21
- Primary completion
- 2023-05-26
- Enrollment
- 853
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.